Embolic Stroke of Undetermined Source and Patent Foramen Ovale Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction

被引:28
|
作者
Strambo, Davide [1 ,2 ]
Sirimarco, Gaia [1 ,2 ]
Nannoni, Stefania [1 ,2 ]
Perlepe, Kalliopi [3 ]
Ntaios, George [3 ]
Vemmos, Kostantinos [4 ]
Michel, Patrik [1 ,2 ]
机构
[1] Lausanne Univ Hosp, Dept Clin Neurosci, Serv Neurol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne, Lausanne, Switzerland
[3] Univ Thessaly, Sch Hlth Sci, Dept Internal Med, Fac Med, Larisa, Greece
[4] Alexandra Hosp, Med Sch Athens, Dept Clin Therapeut, Athens, Greece
关键词
atrial fibrillation; Bayes theorem; embolic stroke; foramen ovale; patent; prevalence; CRYPTOGENIC STROKE; MEDICAL THERAPY; ISCHEMIC-STROKE; CLOSURE; REGISTRY;
D O I
10.1161/STROKEAHA.120.032453
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose: The Risk of Paradoxical Embolism (RoPE) score stratifies patients with stroke according to the probability of having a patent foramen ovale (PFO), which (through Bayes theorem and simple assumptions) can be used to estimate the probability that a PFO is pathogenic in a given subgroup of patients with specific features (ie, a given RoPE score value): a higher PFO prevalence corresponds to a higher probability that a PFO is pathogenic. Among alternative mechanisms in embolic stroke of undetermined source (ESUS), the actual stroke cause may be covert atrial fibrillation. We aimed to validate the RoPE score in a large ESUS population and investigate the rate of stroke recurrence and new incident atrial fibrillation during follow-up according to PFO status and RoPE score. Methods: We pooled data of consecutive patients with ESUS from 3 prospective stroke registries. We assessed RoPE score's calibration and discrimination for the presence of PFO (and consequently for the probability that it is pathogenic). Multivariate logistic regression analysis was performed to identify factors associated with PFO. Results: Among 455 patients with ESUS (median age 59 years), 184 (40%) had PFO. The RoPE score's area under the receiver operating characteristic curve was 0.75. In addition to RoPE score variables, absence of left ventricular hypertrophy, absence of atherosclerosis, and infratentorial lesions were independently associated with PFO. In patients with PFO and RoPE 7 to 10, PFO and RoPE 0 to 6, and without PFO, new incident atrial fibrillation rate was 3.1%, 20.5%, and 31.8%, respectively (log-rank test=6.28, P=0.04). Stroke recurrences in patients with likely pathogenic PFO were not statistically different from other patients. Conclusions: This multicenter study validates the RoPE score to predict the presence/absence of PFO in patients with ESUS, which strongly suggests that RoPE score is helpful in identifying patients with ESUS with pathogenic versus incidental PFOs. Left ventricular hypertrophy, atherosclerosis, and infratentorial stroke may further improve the score. Low RoPE scores were associated with more incidental atrial fibrillation during 10-year follow-up.
引用
收藏
页码:1643 / 1652
页数:10
相关论文
共 50 条
  • [1] Migraine And Embolic Stroke Of Undetermined Source: Thinking Beyond Patent Foramen Ovale And Paradoxical Embolism
    Alshaer, Qasem N.
    Rangaraju, Srikant
    Nahab, Fadi B.
    STROKE, 2022, 53
  • [2] Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source
    von Falkenhausen, Aenne S.
    Keidel, Linus M.
    Wischmann, Johannes
    Hoeglinger, Guenter
    Massberg, Steffen
    Kaeaeb, Stefan
    Kellert, Lars
    Sinner, Moritz F.
    EUROPACE, 2024, 26 (06):
  • [3] Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale
    Zhang, Meng
    Xiao, Qi
    Wang, Kun
    Yin, Ruihua
    Liu, Guangzhen
    Zhao, Hongqin
    Li, Peng
    Zhu, Xiaoyan
    Pan, Xudong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 402
  • [4] Coagulation Testing In Embolic Stroke Of Undetermined Source Suggests A Low Frequency Of Paradoxical Embolism In Patients With A Patent Foramen Ovale
    Alshaer, Qasem N.
    Rangaraju, Srikant
    Nahab, Fadi B.
    STROKE, 2022, 53
  • [5] Atrial Cardiopathy and Likely Pathogenic Patent Foramen Ovale in Embolic Stroke of Undetermined Source
    Leventis, Ioannis A.
    Sagris, Dimitrios
    Strambo, Davide
    Perlepe, Kalliopi
    Sirimarco, Gaia
    Nannoni, Stefania
    Korompoki, Eleni
    Manios, Efstathios
    Makaritsis, Konstantinos
    Vemmos, Konstantinos
    Michel, Patrik
    Ntaios, George
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 361 - 365
  • [6] Carotid Atherosclerosis and Patent Foramen Ovale in Embolic Stroke of Undetermined Source
    Ntaios, George
    Sagris, Dimitrios
    Strambo, Davide
    Perlepe, Kalliopi
    Sirimarco, Gaia
    Georgiopoulos, Georgios
    Nannoni, Stefania
    Korompoki, Eleni
    Manios, Efstathios
    Makaritsis, Konstantinos
    Vemmos, Konstantinos
    Michel, Patrik
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (01):
  • [7] PREVALENCE OF ATRIAL CARDIOPATHY IN EMBOLIC STROKE OF UNDETERMINED SOURCE AND LIKELY PATHOGENIC PATENT FORAMEN OVALE
    Leventis, I.
    Sagris, D.
    Strambo, D.
    Perlepe, K.
    Sirimarco, G.
    Nannoni, S.
    Korompoki, E.
    Manios, E.
    Makaritsis, K.
    Vemmos, K.
    Michel, P.
    Ntaios, G.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 87 - 87
  • [8] Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale
    Toh, Keith Zhi Xian
    Koh, Ming Yi
    Ho, Jamie S. Y.
    Ong, Kathleen Hui Xin
    Lee, Yong Qin
    Chen, Xintong
    Fang, Jun Tao
    Chong, Elliot Yeung
    Lim, Isis Claire Z. Y.
    Teo, Yao Hao
    Teo, Yao Neng
    Chua, Christopher Y. K.
    Lim, Yinghao
    Chan, Bernard P. L.
    Sharma, Vijay K.
    Yeo, Leonard L. L.
    Sia, Ching Hui
    Tan, Benjamin Y. Q.
    CEREBROVASCULAR DISEASES, 2023, 52 (05) : 503 - 510
  • [9] PATENT FORAMEN OVALE, STROKE AND PARADOXICAL EMBOLISM
    MAS, JL
    CEREBROVASCULAR DISEASES, 1991, 1 (04) : 181 - 183
  • [10] Frequency of Hypercoagulability in Patients With Embolic Stroke of Undetermined Source and Patent Foramen Ovale
    Liu, Michael
    Rangaraju, Srikant
    Duncan, Alexander
    Belagaje, Samir
    Belair, Trina
    Henriquez, Laura
    Nahab, Fadi
    STROKE, 2020, 51